PI3K / Akt / mTOR

Items 1 to 50 of 271 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction
  1. Palomid 529 (P529)

    Catalog No. A10693
    Quick View
    AKT Inhibitor
    Palomid 529 is a dual TORC1/2 inhibitor of the PI3K/Akt/mTOR pathway having broad activity in angiogenesis and cellular proliferation. Learn More
  2. GDC-0068 (Ipatasertib, RG-7440)

    Catalog No. A11246
    Quick View
    Akt Inhibitor
    GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in cell-free assays Learn More
  3. TIC10 isomer

    Catalog No. A12720
    Quick View
    AKT inhibitor‎
    TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Learn More
  4. 10-DEBC HCl

    Catalog No. A13590
    Quick View
    AKT/PKB inhibitor‎
    10-DEBC HCl is a selective inhibitor of Akt/PKB. It inhibits IGF-1-stimulated phosphorylation and activation of Akt (complete inhibition at 2.5 μM), suppressing downstream activation of mTOR, p70 S6 kinase and S6 ribosomal protein. Learn More
  5. SR-13668

    Catalog No. A13554
    Quick View
    AKT inhibitor‎
    SR-13668 is an Akt inhibitor, is also an orally bioavailable indole-3-carbinol (I3C) analogue inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic and antiangiogenic activities. Learn More
  6. Afuresertib HCl

    Catalog No. A13030
    Quick View
    AKT inhibitor‎
    Afuresertib, also known as GSK2110183, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. It binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents. Learn More
  7. SC79

    Catalog No. A15541
    Quick View
    Akt phosphorylation activator
    SC79 is an AKT activator. SC79 binds to the plecktrin homology (PH) domain of Akt that mimics the binding of PtdIns(3,4,5)P3 to induce a conformational change in Akt that enhances phosphorylation and activation. Learn More
  8. GSK2141795 (Uprosertib, GSK795)

    Catalog No. A15809
    Quick View
    Akt inhibitor
    Akt inhibitor GSK2141795 binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Learn More
  9. SC 66

    Catalog No. A12081
    Quick View
    Akt inhibitor
    SC 66 is an allosteric inhibitor of Akt that facilitates both ubiquitination and deactivation of Akt. It exhibits anticancer activity in vitro and in vivo. Learn More
  10. TIC10

    Catalog No. A15903
    Quick View
    Akt Inhibitor‎
    TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2. Learn More
  11. Akt1 and Akt2-IN-1

    Catalog No. A16285
    Quick View
    AKT 1/2 inhibitor
    Akt1 and Akt2-IN-1 is an allosteric inhibitor of Akt1 (IC50 = 3.5 nM) and Akt2 (IC50 = 42 nM), with potent and balanced activity. Learn More
  12. ARQ-092 (Miransertib)

    Catalog No. A16286
    Quick View
    AKT inhibitor
    ARQ 092 is an oral activie, potent and selective AKT inhibitor with IC50 values: 5.0 nM (AKT1); 4.5 nM (AKT2); 16 nM (AKT3). Learn More
  13. MK-2206 2HCl

    Catalog No. A10003
    Quick View
    AKT Inhibitor
    MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively. Learn More
  14. Perifosine (NSC-639966)

    Catalog No. A10709
    Quick View
    Akt inhibitor
    Perifosine (also KRX-0401) acts as an Akt inhibitor and a PI3K inhibitor. Learn More
  15. PF-04691502

    Catalog No. A11024
    Quick View
    PI3K/mTOR Inhibitor
    PF-04691502 is a PI3K/mTOR kinase inhibitor, is also an agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway. Learn More
  16. GSK690693

    Catalog No. A11030
    Quick View
    AKT inhibitor
    GSK690693 is a novel ATP-competitive, low-nanomolar pan-Akt kinase inhibitor (IC50 values are 2, 13 and 9 nM of Akt1, 2 and 3 respectively). Learn More
  17. AT7867

    Catalog No. A10094
    Quick View
    AKT inhibitor
    AT7867 is a novel and potent inhibitor of both AKT and the downstream kinase p70 S6 kinase (p70S6K) and also of protein kinase A. Learn More
  18. CCT128930

    Catalog No. A11031
    Quick View
    AKT Inhibitor
    CCT128930 is an ATP-competitive AKT inhibitor that is a potent, advanced lead pyrrolopyrimidine compound exhibiting selectivity for AKT over PKA, achieved by targeting a single amino acid difference. Learn More
  19. PHT-427

    Catalog No. A11032
    Quick View
    AKT Inhibitor
    PHT-427 is a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor. Learn More
  20. Triciribine phosphate (NSC-280594)

    Catalog No. A11033
    Quick View
    AKT Inhibitor
    Triciribine phosphate inhibits the phosphorylation, activation, and signalling of Akt-1, -2, and -3, which may result in the inhibition of Akt-expressing tumor cell proliferation. Learn More
  21. A-674563

    Catalog No. A11034
    Quick View
    Akt inhibitor
    A-674563 is a B/Akt inhibitor with an IC50 of 14 nM and also shows inhibitory activity against PKA and CDK2 with IC50 of 16 and 46 nM, respectively. Learn More
  22. Honokiol

    Catalog No. A10453
    Quick View
    Antiangiogenic and Antitumor Agent
    Honokiol is a lignan present in the cones, bark, and leaves of Magnolia grandiflora that has shown pro-apoptotic effects in melanoma, sarcoma, myeloma, leukemia, bladder, lung, prostate, oral squamous cell carcinoma and colon cancer cell lines. Learn More
  23. AKT inhibitor VIII (AKTI-1/2)

    Catalog No. A11286
    Quick View
    AKT inhibitor
    AKT inhibitor VIII is a cell-permeable and reversible quinoxaline compound that potently and selectively inhibits Akt1/Akt2 activity (IC50 = 58 nM, 210 nM, and 2.12 μM for Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays). Learn More
  24. A-443654

    Catalog No. A11287
    Quick View
    Akt inhibitor
    A-443654, a specific Akt inhibitor with Ki value of 160 pM, interferes with mitotic progression and bipolar spindle formation. Learn More
  25. AZD5363

    Catalog No. A11759
    Quick View
    AKT inhibitor
    AZD5363 is a potent inhibitor of AKT with pharmacodynamic activity in vivo, has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent. Learn More
  26. KP372-1

    Catalog No. A12877
    Quick View
    Akt Inhibitor
    KP372-1 is a synthetic small molecule AKT inhibitor. Learn More
  27. Deguelin

    Catalog No. A13460
    Quick View
    Deguelin is a natural product that displays profound antiproliferative activity. Learn More
  28. Triciribine

    Catalog No. A13210
    Quick View
    AKT Inhibitor
    Triciribine, also known as API-2, suppresses the phosphorylation level and kinase activity of Akt. Learn More
  29. Akt-l-1

    Catalog No. A12435
    Quick View
    AKT1 inhibitor
    Akt-I-1 is a specific inhibitor of Akt1 (IC(50) 4.6 µM) and does not inhibit AKT2, or AKT3 Learn More
  30. AT13148

    Catalog No. A12464
    Quick View
    multi-AGC kinase inhibitor
    AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors. Learn More
  31. Miltefosine

    Catalog No. A14138
    Quick View
    PI3K/Akt inhibitor
    Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 μM and 8.1 μM in carcinoma cell lines A431 and HeLa Learn More
  32. AT7867 2HCl

    Catalog No. A15006
    Quick View
    Akt inhibitor
    AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1/2/3 and p70S6K/PKA with IC50 of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively, little activity outside the AGC kinase family. Learn More
  33. Tomatidine

    Catalog No. A16233
    Quick View
    ERK/Akt/NF-kB inhibitor
    Tomatidine inhibits the phosphorylation of ERK, Akt, and the nuclear content of NF-kB. possess anti-inflammatory properties. Learn More
  34. Afuresertib

    Catalog No. A16392
    Quick View
    Akt inhibitor
    Afuresertib is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2. Learn More
  35. Borussertib

    Catalog No. A13364
    Quick View
    Akt inhibitor
    Borussertib is a covalent-allosteric and first-in-class inhibitor of protein kinase Akt, with an IC50 of 0.8 nM and a Ki of 2.2 nM for Aktwt. Learn More
  36. AKT Kinase Inhibitor

    Catalog No. A11285
    Quick View
    Akt kinase inhibitor
    AKT Kinase Inhibitor is an Akt kinase inhibitor with anti-tumor activity. Learn More
  37. Isobavachalcone

    Catalog No. A11453
    Quick View
    Akt inhibitor
    Isobavachalcone (Corylifolinin) is derived from Psoralea corylifolia Linn. and is a potent inhibitor of Akt signaling pathway, which induces apoptosis in human cancer cells (Inhibits OVCAR-8 cell growth with an IC50 value of 7.92 μM). Learn More
  38. 3CAI

    Catalog No. A20924
    Quick View
    AKT1/AKT2 inhibitor
    3CAI is a potent and specific AKT1 and AKT2 inhibitor. Learn More
  39. Solenopsin

    Catalog No. A21087
    Quick View
    ATP-competitive AKT inhibitor
    Solenopsin is an ATP-competitive AKT inhibitor with IC50 value of 10 μM . Learn More
  40. YS-49

    Catalog No. A21198
    Quick View
    PI3K/Akt activator
    YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. Learn More
  41. Ipatasertib dihydrochloride

    Catalog No. A21734
    Quick View
    pan-Akt inhibitor
    Ipatasertib dihydrochloride (GDC-0068 dihydrochloride) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5/18/8 nM, 620-fold selectivity over PKA. Learn More
  42. PF-AKT400

    Catalog No. A21991
    Quick View
    Akt inhibitor
    PF-AKT400 is a broadly selective, potent, ATP-competitive Akt inhibitor, displays 900-fold greater selectivity for PKBα (IC50=0.5 nM) than PKA (IC50=450 nM). Learn More
  43. AKT-IN-1

    Catalog No. A21009
    Quick View
    AKT inhibitor
    AKT-IN-1 is an allosteric AKT inhibitor with an IC50 of 1.042 μM. Learn More
  44. PP121

    Catalog No. A11207
    Quick View
    PI3K Inhibitor
    PP121 is a dual inhibitor of receptor tyrosine kinases (RTKs) (IC50 < 0.02 μM for Abl, Src, VEGFR-2 and PDGFR) and PI 3-K family kinases (IC50 < 0.06 μM for p110α, DNA-PK and mTOR). Learn More
  45. VS-5584

    Catalog No. A12480
    Quick View
    PI3K/mTOR inhibitor
    VS-5584 is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer. Learn More
  46. HS-173

    Catalog No. A13021
    Quick View
    PI3K Inhibitor
    HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis. Learn More
  47. Panulisib (P7170, AK151761)

    Catalog No. A14379
    Quick View
    PI3K inhibitor
    Panulisib is a potent and selective imidazoquinoline based PI3K inhibitor with potential anticancer activity. Learn More
  48. AZD8186

    Catalog No. A14164
    Quick View
    PI3K inhibitor
    AZD8186 is and inhibitor of the beta isoform of phosphoinositide-3 kinase (PI3K), with potential antineoplastic activity. Learn More
  49. CAL-130

    Catalog No. A15030
    Quick View
    PI3K inhibitor
    CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3Kδ/γ as therapy for T cell acute lymphoblastic leukemia (T-ALL). Learn More
  50. CAL-130 Hydrochloride

    Catalog No. A15031
    Quick View
    PI3K inhibitor
    CAL-130 Hydrochloride is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3Kδ/γ as therapy for T cell acute lymphoblastic leukemia (T-ALL). Learn More

Items 1 to 50 of 271 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction
Rewards